Immunosuppressants

Results: 1821



#Item
411Medicine / Centocor / Psoriasis / Autoimmune diseases / Ustekinumab / Infliximab / Adalimumab / Etanercept / Immunosuppressants / Monoclonal antibodies / Pharmacology

Severe chronic plaque psoriasis Initial PBS authority application and supporting information Who needs to complete this form

Add to Reading List

Source URL: www.humanservices.gov.au

Language: English - Date: 2014-09-09 22:04:36
412Monoclonal antibodies / Psoriasis / Placebo / Ustekinumab / Alefacept / Medicine / Immunosuppressants / Health

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COSENTYX safely and effectively. See full prescribing information for COSENTYX. ---------------------------------CO

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2015-01-22 14:01:35
413Health / Rheumatoid arthritis / Disease-modifying antirheumatic drug / Leflunomide / Infliximab / Abatacept / Rituximab / Arthritis / Methotrexate / Immunosuppressants / Medicine / Pharmacology

Rheumatoid arthritis Initial PBS authority application Supporting information When to use this form This form must be completed by a rheumatologist or clinical

Add to Reading List

Source URL: www.humanservices.gov.au

Language: English - Date: 2014-09-09 23:29:58
414Health / Rheumatoid arthritis / Disease-modifying antirheumatic drug / Methotrexate / Adalimumab / Rituximab / Infliximab / Abatacept / Etanercept / Immunosuppressants / Medicine / Immunology

APRIL[removed]This month n Spotlight

Add to Reading List

Source URL: www.hkma.org

Language: English - Date: 2013-05-09 08:50:54
415Type 1 hypersensitivity / Autoimmune diseases / Immunosuppressants / Macrolides / Eczema / Atopic dermatitis / Atopy / Dermatitis / International Study of Asthma and Allergies in Childhood / Medicine / Health / Immunology

Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Background Materials Meeting Package Dermatologic and Ophthalmic Drugs Advisory Committee

Add to Reading List

Source URL: www.fda.gov

Language: English
416Immunology / Arthritis / Autoimmune diseases / Rheumatoid arthritis / Abatacept / Biologic / Tuberculosis treatment / Methotrexate / Aspirin / Medicine / Health / Immunosuppressants

PATIENT INFORMATION ON ABATACEPT (Brand name: Orencia) This information sheet has been produced by

Add to Reading List

Source URL: www.rheumatology.org.au

Language: English - Date: 2014-03-20 01:03:02
417Recombinant proteins / Amgen / Etanercept / Wyeth / Adalimumab / Syringe / Interferon alfa / Pharmacology / Medicine / Immunosuppressants

7 October[removed]removed] RE: Public Consultation on Authority Required Medicines for the Post-Market Review of Authority Required PBS Listings

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-04 00:10:33
418Immune system / Pharmaceuticals policy / Immunosuppressants / Natalizumab / Pharmaceutical Benefits Scheme / Interferon beta-1a / Immunology / Multiple sclerosis / Medicine

PBAC Secretariat MDP 952 Department of Health and Ageing GPO Box 9848 Canberra ACT[removed]October 2014

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-04 00:10:33
419Healthcare in Australia / Eculizumab / Immunosuppressants / Hemolytic-uremic syndrome / Pharmaceutical Benefits Scheme / Medicare / Dialysis / Medical prescription / Medicine / Health / Nephrology

Atypical Haemolytic Uraemic Syndrome (aHUS) - eculizumab - Continuing PBS authority application

Add to Reading List

Source URL: www.humanservices.gov.au

Language: English - Date: 2015-03-05 22:46:33
420Health / Monoclonal antibodies / Centocor / Rheumatology / Autoimmune diseases / Infliximab / Ankylosing spondylitis / Etanercept / Adalimumab / Medicine / Pharmacology / Immunosuppressants

Ankylosing spondylitis Continuing PBS authority application Supporting information Purpose of this form Authority prescription form

Add to Reading List

Source URL: www.humanservices.gov.au

Language: English - Date: 2015-02-11 18:54:25
UPDATE